1. Home
  2. Analysis
  3. Pomalyst
  4. Gaviscon

Pomalyst and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pomalyst (pomalidomide) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include back pain among females and alopecia among males.

The phase IV clinical study analyzes what interactions people have when they take Pomalyst and Gaviscon. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

On Aug, 09, 2026

25 people who take Pomalyst and Gaviscon together, and have interactions are studied.

Pomalyst and Gaviscon drug interactions.

What are the common drug interactions of Pomalyst and Gaviscon, by gender? *:

female:

  1. Back pain
  2. Abdominal discomfort
  3. Dyspnoea (difficult or laboured respiration)
  4. Regurgitation (expulsion of material)
  5. Cough
  6. Muscle spasms (muscle contraction)
  7. Myalgia (muscle pain)
  8. Asthma
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Alopecia (absence of hair from areas of the body)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Decreased appetite
  4. Weight decreased
  5. Back disorder
  6. Dehydration (dryness resulting from the removal of water)
  7. Diarrhoea

What are the common drug interactions of Pomalyst and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Adverse drug reaction
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Heart rate increased
  4. Weight decreased
  5. Dehydration (dryness resulting from the removal of water)
  6. Diarrhoea
  7. Abdominal discomfort
  8. Alopecia (absence of hair from areas of the body)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Febrile neutropenia (fever with reduced white blood cells)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 24 people, 96.00%
  2. Allergies: 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pomalyst and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pomalyst and Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pomalyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pomalyst and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gaviscon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pomalidomide and aluminum hydroxide; magnesium trisilicate (the active ingredients of Pomalyst and Gaviscon, respectively), and Pomalyst and Gaviscon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.